|
|
 |
 | Medical News Releases > News Topics > Medical Science >
Cancer
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is an international leader in patient care, cancer research, prevention, education and community outreach and a National Cancer Institute-designated Cancer Center.
Learn more about the advances in cancer research through the news stories and experts listed below.
| Faculty Experts: |
Showing Cancer Experts 1 through 5 of 21.
- Show More |
|
Matthew Kreuter
Professor
Matt Kreuter is a leading national public health expert in the field of health communications.
Expertise: Health communication, cancer prevention and control, health disparities
Direct contact: 314-935-3701
/
mkreuter@wustl.edu
|
Graham Colditz
Associate Director, Prevention and Control, Siteman Cancer Center
 |
| Colditz |
Dr. Colditz is an Epidemiologist and Associate Director for Prevention and Control at the Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri. He is the Niess-Gain Family Professor in Medicine, Department of Surgery, at Washington ...
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
Dione Farria
Assistant Professor of Radiology
Dione Farria is Co-Director for the Alvin J. Siteman Cancer Center Program for the Elimination of Cancer Disparities (PECaD) and an assistant professor of Radiology, Division of Diagnostic Radiology, Section of Breast Imaging. She is certified by the American Board of Radiology and American Board of ...
Expertise: Breast imaging, breast cancer, doctor-patient communication
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
David Gutmann, M.D., Ph.D.
Donald O. Schnuck Family Professor of Neurology
Gutmann is the founder and director of the Neurofibromatosis Clinical Program, which is dedicated to treating the common inherited tumor predisposition syndrome, neurofibromatosis (NF). Individuals with NF have an increased risk of developing brain tumors and other cancers. As national leader in the ...
Expertise: Brain tumors, cancer genetics, neurofibromatosis, molecular genetics, neurosciences, neurology
Media assistance: (314) 286-0122 / purdym@wustl.edu
|
Michael DeBaun
Professor of Pediatrics, Biostatistics and Neurology
Dr. DeBaun is a professor of pediatrics, biostatistics and neurology and directs the Sickle Cell Medical Treatment and Education Center at St. Louis Children's Hospital. He is board-certified in pediatrics and pediatric hematology/oncology. He received a MPH in epidemiology from The Johns Hopkins University ...
Expertise: overgrowth cancer predisposition syndromes, public health issues, sickle cell disease
Media assistance: (314) 286-0120 / westerhousej@wustl.edu
|
Showing Cancer Experts 1 through 5 of 21.
- Show More |
|
| News Stories & Tip Sheets: |
Showing Cancer Stories 1 through 3 of 229.
- Show More |
|
Safe summer fun
Sun goers should protect themselves from harmful UV rays
June 15,
2009 -- Summertime is beach time, swimming pool time and gardening time. Most of us spend a lot more time in the sun during the summer months than during the rest of the year, and Washington University dermatologists say it's very important to protect ourselves from the sun's damaging rays.
|
Unraveling radiation resistance
Researchers find how a common genetic mutation makes cancer radiation resistant
June 8,
2009 -- Many cancerous tumors possess a genetic mutation that disables a tumor suppressor called PTEN. Now researchers at the School of Medicine have shown why inactivation of PTEN allows tumors to resist radiation therapy. The PTEN gene produces a protein found in almost all tissues in the body. This protein acts as a tumor suppressor by preventing cells from growing and dividing too rapidly.
|
Scoping out cancer-causing disorder
Technique eradicates problems in most patients with Barrett's esophagus
May 27,
2009 --
A procedure that uses heat generated by radio waves to treat Barrett's esophagus, a condition caused by acid reflux (severe heartburn), can eliminate signs of the potentially cancer-causing disorder and reduce the risk that the disease will progress.
|
Showing Cancer Stories 1 through 3 of 229.
- Show More |
|
Elaine Mardis and Richard Wilson: Taking Cancer's Genetic Measure
U.S. News & World Report online
July 1,
2009 -- WUSTL biochemists Elaine Mardis and Richard Wilson helped decode the human genome and are now working to find genetic mutations associated with acute myeloid leukemia.
|
Jobs Had Liver Transplant
The Wall Street Journal
June 22,
2009 -- Steve Jobs, who has been on medical leave from Apple Inc. since January to treat an undisclosed medical condition, received a controversial liver transplant in Tennessee about two months ago. The chief executive has been recovering well and is expected to return to work on schedule later this month, though he may work part-time initially. WUSTL pancreatic and gastrointestinal surgery professor William Hawkins and surgery professor William Chapman both comment.
|
Gene Mutation May Up Risks of Endometrial Cancer
U.S. News & World Report online
and 8 others
May 27,
2009 -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. WUSTL gynecologic oncologist Israel Zighelboim comments on the study that appears online in the Journal of Clinical Oncology.
|
Study: Drug lowers risk of getting prostate cancer
Associated Press
and 52 others
April 28,
2009 -- A drug already sold for other prostate problems significantly cut the chances of prostate cancer being found in men with an increased risk of the disease, doctors reported Monday. The U.S. study was led by WUSTL urologic surgeon Gerald Andriole, who comments.
|
Luminol used to ID immune inflammation
United Press International
and 5 others
March 24,
2009 -- WUSTL scientists led by WUSTL radiology professor David Piwnica-Worms and lead author and postdoctoral fellow Shimon Gross say they've discovered luminol -- a compound used at crime scenes to make blood residue glow -- can also identify immune inflammation.
|
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
| |
|
| | |
|
Download
Show More Cancer Clips
Print ready page